Tonix Pharmaceuticals Hosts Webinar on Groundbreaking Fibromyalgia Treatment
On February 14, 2024, Tonix Pharmaceuticals Holding Corp., a renowned biopharmaceutical company, hosted a webinar featuring key opinion leaders (KOLs)...
Immersion and Meta Platforms Inc Form Groundbreaking Partnership
On February 14, 2024, a groundbreaking partnership was formed as Immersion and Meta Platforms, Inc. (previously known as Facebook Inc.)...
Biotricitys Impressive Financial Progress and Commitment to Excellence
Biotricity, a leading healthcare technology company, has recently released its preliminary Q3 2024 results, showcasing remarkable progress in various key...
Collaboration Between Erasca Inc and Novartis to Advance Clinical Development of Combination Therapy for Solid Tumors and Melanoma
On February 14, 2024, Erasca, Inc. announced its collaboration with Novartis through two clinical trial collaboration and supply agreements. The...
Great Lakes Dredge Dock Exceeds Earnings Expectations
On February 14, 2024, Great Lakes Dredge & Dock (NASDAQ: GLDD) pleasantly surprised investors with their quarterly earnings. They reported...
Analyst Ratings and Price Targets for SentinelOne
As of February 14, 2024, SentinelOne (NYSE: S) has received various analyst ratings in the past three months. Here is...
Nuvve Holding Corp Leading the Way in VehicletoGrid Technology
On February 14, 2024, Nuvve Holding Corp. (NASDAQ: NVVE) stands at the forefront of groundbreaking vehicle-to-grid (V2G) technology. This innovative...
Analyst Upgrades Lyft Rating and Raises Price Target
On February 14, 2024, MoffettNathanson analyst Michael Morton made a significant upgrade to Lyft (NASDAQ: LYFT). With a revised price...
Analyst Ratings and Price Targets for NBT Bancorp Mixed Sentiment and Varying Expectations
As of February 14, 2024, the analyst ratings for NBT Bancorp (NASDAQ:NBTB) in the past three months have shown some...
Unveiling the Role of Inflammation and ASC Specks in Neurological Diseases A Milestone in Therapeutic Advancements
On February 14, 2024, a groundbreaking review article was unveiled by ZyVersa Therapeutics, shedding light on a crucial aspect of...
Don't Miss It
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
